A Multidisciplinary Approach to the Treatment of COVID-Associated Complications After Pancreatoduodenal Resection (Case Report)

We report a clinical case of treatment of a complicated postoperative course in a patient who underwent pancreatoduodenal resection associated with coronavirus infection. Prevention and treatment of such complications have been suggested.
Pancreatoduodenal resection (PDR) is indicated for malignant tumors of the pancreatic head, duodenum or its large papilla, distal common bile duct, as well as in chronic pancreatitis with a predominant lesion of the pancreatic head with severe pain syndrome.
The given clinical observation describes an example of treatment of a patient who developed a series of thromboembolic complications in the early stages after PDR performed for a neuroendocrine tumor of the pancreatic head. The oncology disease, extensive surgery such as PDR, and the postoperative period itself are risk factors for the development of various thromboembolic complications. According to the literature, the incidence of thromboembolic complications after PDR is 3–3.3%.
The reason for the atypical course of the postoperative period when performing pancreatoduodenal resection in patients with tumor of the pancreas may be conditions that are not directly related to either the pathology of the pancreas or the features of the surgical intervention. When analyzing the patient’s condition, one should take into account the conditions of treatment. In such situations, proper detection of COVID-19 and adequate correction of therapy can fundamentally change the outcome of the disease.

1. Chissov VI, Trakhtenberg AKh, Paches AI. (eds.) Atlas onkologicheskikh operatsiy. Moscow: GEOTAR-Media Publ.; 2008. (in Russ.).

2. Khatkov IE, Tsvirkun VV, Izrailov RE, Mikhnevich MV, Vasnev OS, Efanov MG, et al. Open, laparoscopic and robot-assisted surgery for periampullary cancer (outcomes, advantages, drawbacks). Annals of HPB Surgery. 2019;24(3):54–64. (in Russ.) https://doi.org/10.16931/1995-5464.2019354-64

3. Fedorov VD, Buriev IM, Ikramov RZ. Khirurgicheskaya pankreatologiya. Moscow: Meditsina Publ.; 1999. (in Russ.)

4. Shchastnyy AT. Posleoperatsionnye oslozhneniya proksimal’nykh rezektsiy podzheludochnoy zhelezy u patsientov s khronicheskim pankreatitom. Novosti khirurgii. 2011;19(3):30–43. (in Russ.).

5. Onopriev VI, Korot’ko GF, Rogal’ ML, Voskanyan SE. Pankreatoduodenal’naya rezektsiya (aspekty khirurgicheskoy tekhniki, funktsional’nye posledstviya). Krasnodar; 2005. (in Russ.).

6. Late Sequelae of COVID¬19. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. November 13, 2020. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/late-sequelae.html (Accessed 20 Feb 2021).

7. Perico L, Benigni A, Casiraghi F, Ng L, Renia L, Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nature reviews. Nephrology. 2021;17(1):46–64. https://doi.org/10.1038/s41581-020-00357-4

8. Vremennye metodicheskie rekomendatsii. Profilaktika, diagnostika i lechenie novoy koronavirusnoy infektsii (COVID¬19). Versiya 8 ot 03.09.2020. Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/051/777/original/030902020_COVID-19_v8.pdf [Accessed 20 Feb 2021]. (in Russ.).

9. Ho CK, Kleeff J, Friess H, Büchler MW. Complications of pancreatic surgery. HPB (Oxford). 2005;7(2):99–108. https://doi.org/10.1080/13651820510028936

10. Tzeng CW, Katz MH, Lee JE, Fleming JB, Pisters PW, Vauthey JN, et al. Predicting the risks of venous thromboembolism versus postpancreatectomy haemorrhage: analysis of 13,771 NSQIP patients. HPB (Oxford). 2014;16(4):373–383. https://doi.org/10.1111/hpb.12148

11. Teshome MK, Najib K, Nwagbara CC, Akinseye OA, Ibebuogu UN. Patent Foramen Ovale: A Comprehensive Review. Curr Probl Cardiol. 2020;45(2):100392. https://doi.org/10.1016/j.cpcardiol.2018.08.004

12. Müller S, Beyer-Westendorf J. Thromboembolic Complications in COVID-19. Dtsch Med Wochenschr. 2020;145(24):1728–1734. https://doi.org/10.1055/a-1198-3639

13. Amraei R, Rahimi N. COVID-19, Renin-Angiotensin System and Endothelial Dysfunction. Cells. 2020;9(7):1652. https://doi.org/10.3390/cells9071652

14. Zhang S, Liu Y, Wang X, Yang L, Li H, Wang Y, et al. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. J Hematol Oncol. 2020;13(1):120. https://doi.org/10.1186/s13045-020-00954-7

15. Leisman DE, Deutschman CS, Legrand M. Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Med. 2020;46(6):1105–1108. https://doi.org/10.1007/s00134-020-06059-6

16. Grobler C, Maphumulo SC, Grobbelaar LM, Bredenkamp JC, Laubscher GJ, Lourens PJ, et al. Covid-19: The Rollercoaster of Fibrin (Ogen), DDimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes. Int J Mol Sci. 2020;21(14):5168. https://doi.org/10.3390/ijms21145168

17. Gavriilaki E, Brodsky RA. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily. Br J Haematol. 2020;189(6):e227–e230. https://doi.org/10.1111/bjh.16783

18. Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020;24(1):360. https://doi.org/ 10.1186/s13054-020-03077-0

19. Merrill JT, Erkan D, Winakur J, James JA. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020;16(10):581–589. https://doi.org/ 10.1038/s41584-020-0474-5